Glycemic Response to Oral Nutrition Supplements

Completed · Not applicable

Conditions studied: Diabetes

In brief

This will be a randomized, cross-over study of two oral nutrition supplements in individuals with Type 2 Diabetes.

Key facts

Study ID

NCT02612675

Run by

Société des Produits Nestlé (SPN)

People needed

13

Starts

2013-01-01

Expected to finish

2013-02-01

Last updated by the study team

2015-11-24

Who can join

Age: 20 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 20-75 yrs
• Type 2 diabetes controlled with diet or diet and oral agent, with the exception of sulfonylureas such as glimepiride (Amaryl), glipizide (Glucotrol/Glucotrol XL) and glyburide (DiaBeta, Micronase, Glynase Prestabs); meglitinides such as reaglinide (Prandin) and nateglinide (Starlix); and alpha-glucosidase inhibitors such as acarbose (Precose) and miglitol (Glyset)
• Hemoglobin A1C less than 9.0%
• Fasting blood glucose less than 180 mg

You may not qualify if…

• Allergy to milk protein or any other component of the formula

Where it is running

• Diabetes & Glandular Disease Clinic, PA — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.